SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-023068
Filing Date
2023-08-10
Accepted
2023-08-10 16:20:30
Documents
15
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atxi20230530_8k.htm   iXBRL 8-K 24858
2 EXHIBIT 99.1 ex_527625.htm EX-99.1 108577
7 a01.jpg GRAPHIC 7824
  Complete submission text file 0001437749-23-023068.txt   286932

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230810.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20230810_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230810_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230810_pre.xml EX-101.PRE 11584
9 EXTRACTED XBRL INSTANCE DOCUMENT atxi20230530_8k_htm.xml XML 2573
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 231159813
SIC: 2834 Pharmaceutical Preparations